Is nutraceutical supplementation appropriate for COVID-19 management?

Allergy Asthma Proc. 2021 May 1;42(3):e103-e105. doi: 10.2500/aap.2021.42.210030.
No abstract available

Publication types

  • Letter

MeSH terms

  • Berberine / therapeutic use
  • COVID-19 / diet therapy*
  • Catechin / analogs & derivatives
  • Catechin / therapeutic use
  • Curcumin / therapeutic use
  • Dietary Supplements*
  • Humans
  • Lactobacillus / physiology
  • NF-E2-Related Factor 2 / metabolism
  • Receptor, Angiotensin, Type 1 / metabolism
  • SARS-CoV-2 / physiology*

Substances

  • AGTR1 protein, human
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Receptor, Angiotensin, Type 1
  • Berberine
  • Catechin
  • epigallocatechin gallate
  • Curcumin